348 related articles for article (PubMed ID: 27990620)
1. Role of Peroxynitrite-Induced Activation of Poly(ADP-Ribose) Polymerase (PARP) in Circulatory Shock and Related Pathological Conditions.
Islam BU; Habib S; Ali SA; Moinuddin ; Ali A
Cardiovasc Toxicol; 2017 Oct; 17(4):373-383. PubMed ID: 27990620
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiological Role of Peroxynitrite Induced DNA Damage in Human Diseases: A Special Focus on Poly(ADP-ribose) Polymerase (PARP).
Islam BU; Habib S; Ahmad P; Allarakha S; Moinuddin ; Ali A
Indian J Clin Biochem; 2015 Oct; 30(4):368-85. PubMed ID: 26788021
[TBL] [Abstract][Full Text] [Related]
3. Peroxynitrite-induced cytotoxicity: mechanism and opportunities for intervention.
Virág L; Szabó E; Gergely P; Szabó C
Toxicol Lett; 2003 Apr; 140-141():113-24. PubMed ID: 12676457
[TBL] [Abstract][Full Text] [Related]
4. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
Henning RJ; Bourgeois M; Harbison RD
Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
[TBL] [Abstract][Full Text] [Related]
5. Structure and function of poly(ADP-ribose) polymerase-1: role in oxidative stress-related pathologies.
Virág L
Curr Vasc Pharmacol; 2005 Jul; 3(3):209-14. PubMed ID: 16026317
[TBL] [Abstract][Full Text] [Related]
6. Peroxynitrite production, DNA breakage, and poly(ADP-ribose) polymerase activation in a mouse model of oxazolone-induced contact hypersensitivity.
Szabó E; Virág L; Bakondi E; Gyüre L; Haskó G; Bai P; Hunyadi J; Gergely P; Szabó C
J Invest Dermatol; 2001 Jul; 117(1):74-80. PubMed ID: 11442752
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide-peroxynitrite-poly(ADP-ribose) polymerase pathway in the skin.
Virág L; Szabó E; Bakondi E; Bai P; Gergely P; Hunyadi J; Szabó C
Exp Dermatol; 2002 Jun; 11(3):189-202. PubMed ID: 12102657
[TBL] [Abstract][Full Text] [Related]
8. Role of the peroxynitrite-poly (ADP-ribose) polymerase pathway in the pathogenesis of liver injury.
Gero D; Szabó C
Curr Pharm Des; 2006; 12(23):2903-10. PubMed ID: 16918420
[TBL] [Abstract][Full Text] [Related]
9. Poly(ADP-ribose) polymerase activation by reactive nitrogen species--relevance for the pathogenesis of inflammation.
Szabó C
Nitric Oxide; 2006 Mar; 14(2):169-79. PubMed ID: 16111903
[TBL] [Abstract][Full Text] [Related]
10. Superoxide, NO, peroxynitrite and PARP in circulatory shock and inflammation.
Esposito E; Cuzzocrea S
Front Biosci (Landmark Ed); 2009 Jan; 14(1):263-96. PubMed ID: 19273067
[TBL] [Abstract][Full Text] [Related]
11. Purines inhibit poly(ADP-ribose) polymerase activation and modulate oxidant-induced cell death.
Virág L; Szabó C
FASEB J; 2001 Jan; 15(1):99-107. PubMed ID: 11149897
[TBL] [Abstract][Full Text] [Related]
12. Poly (adp-ribose) polymerase inhibitors as potential therapeutic agents in stroke and neurotrauma.
Komjáti K; Besson VC; Szabó C
Curr Drug Targets CNS Neurol Disord; 2005 Apr; 4(2):179-94. PubMed ID: 15857303
[TBL] [Abstract][Full Text] [Related]
13. Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease.
Pacher P; Szabo C
Am J Pathol; 2008 Jul; 173(1):2-13. PubMed ID: 18535182
[TBL] [Abstract][Full Text] [Related]
14. The pathogenesis of diabetic complications: the role of DNA injury and poly(ADP-ribose) polymerase activation in peroxynitrite-mediated cytotoxicity.
Kiss L; Szabó C
Mem Inst Oswaldo Cruz; 2005 Mar; 100 Suppl 1():29-37. PubMed ID: 15962096
[TBL] [Abstract][Full Text] [Related]
15. Role of redox signaling and poly (adenosine diphosphate-ribose) polymerase activation in vascular smooth muscle cell growth inhibition by nitric oxide and peroxynitrite.
Huang J; Lin SC; Nadershahi A; Watts SW; Sarkar R
J Vasc Surg; 2008 Mar; 47(3):599-607. PubMed ID: 18295111
[TBL] [Abstract][Full Text] [Related]
16. Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion.
Szabó C; Dawson VL
Trends Pharmacol Sci; 1998 Jul; 19(7):287-98. PubMed ID: 9703762
[TBL] [Abstract][Full Text] [Related]
17. Modulating poly (ADP-ribose) polymerase activity: potential for the prevention and therapy of pathogenic situations involving DNA damage and oxidative stress.
Decker P; Muller S
Curr Pharm Biotechnol; 2002 Sep; 3(3):275-83. PubMed ID: 12164482
[TBL] [Abstract][Full Text] [Related]
18. The therapeutic potential of poly(ADP-ribose) polymerase inhibitors.
Virág L; Szabó C
Pharmacol Rev; 2002 Sep; 54(3):375-429. PubMed ID: 12223530
[TBL] [Abstract][Full Text] [Related]
19. Alternative mechanisms of inhibiting activity of poly (ADP-ribose) polymerase-1.
Sriram CS; Jangra A; Bezbaruah BK; V AK; Sykam S
Front Biosci (Schol Ed); 2016 Jan; 8(1):123-8. PubMed ID: 26709902
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiologic role of oxidative stress-induced poly(ADP-ribose) polymerase-1 activation: focus on cell death and transcriptional regulation.
Erdélyi K; Bakondi E; Gergely P; Szabó C; Virág L
Cell Mol Life Sci; 2005 Apr; 62(7-8):751-9. PubMed ID: 15868400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
